STOCK TITAN

30,000 CRSP shares to be sold under Rule 144 by shareholder

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of common stock in CRSP has filed a notice of proposed resale under Rule 144. The filing covers the planned sale of 30,000 shares of common stock through Goldman Sachs & Co. LLC on the NASD, with an aggregate market value of $1,578,300. The shares are part of a larger base of 95,300,233 common shares outstanding.

The securities to be sold were acquired as compensation through restricted stock awards from the issuer in multiple grants dated between 2018 and 2025, each labeled as compensation on the acquisition and payment dates. The person for whose account the sale is to be made represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many CRSP shares are proposed to be sold under this Rule 144 notice?

The notice covers a proposed sale of 30,000 shares of CRSP common stock under Rule 144.

What is the aggregate market value of the CRSP shares to be sold?

The aggregate market value of the 30,000 common shares to be sold is stated as $1,578,300.

How many CRSP common shares are outstanding according to this filing?

The filing states that there are 95,300,233 common shares outstanding of the issuer.

How were the CRSP shares being sold under Rule 144 originally acquired?

The shares listed were acquired as compensation through restricted stock awards from the issuer on various dates between 2018 and 2025.

Which broker will handle the planned sale of CRSP shares?

The proposed sale of 30,000 CRSP common shares is to be executed through Goldman Sachs & Co. LLC.

On which market is the CRSP Rule 144 sale expected to occur and when?

The filing lists the NASD as the securities exchange and gives an approximate sale date of 01/20/2026.

What representation does the CRSP selling holder make about issuer information?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Crispr Therapeut

NASDAQ:CRSP

CRSP Rankings

CRSP Latest News

CRSP Latest SEC Filings

CRSP Stock Data

5.80B
93.75M
1.64%
80.94%
24.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Switzerland
ZUG